Chimerix: This Misunderstood Biotech, Trading Near Cash, Offers Substantial Upside – Seeking Alpha
Seeking Alpha |
Chimerix: This Misunderstood Biotech, Trading Near Cash, Offers Substantial Upside
Seeking Alpha Brincidofovir has shown in vitro efficacy against all of the families of DNA viruses that affect humans – cytomegalovirus (CMV), adenovirus, BK virus, and herpes simplex viruses. Brincidofovir should be approved as the first antiviral smallpox … and more » |